Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-011323
Filing Date
2020-04-27
Accepted
2020-04-27 06:05:22
Documents
1
Period of Report
2020-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5721
  Complete submission text file 0000899243-20-011323.txt   7051
Mailing Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000
Business Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000 61(0)3 8692-7222
Benitec Biopharma Inc. (Issuer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000
Business Address
Boston Megan (Reporting) CIK: 0001808923 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39267 | Film No.: 20817077